Skip to content
777 Sourcing.

Capability

development and commercialisation of polyclonal antibodies

Suppliers
1
States & provinces
1
Countries
1

1 development and commercialisation of polyclonal antibodies supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

IMMURON LIMITED

CARLTON, Victoria

Immuron Limited is a commercial and clinical stage publicly listed Australian biopharmaceutical company that has pioneered an innovative platform technology focused on development and commercialization of a novel class of orally delivered polyclonal antibodies for enteric disease prevention and treatment. Founded and incorporated in Australia in 1994, it has been listed on the ASX since April 30, 1999 under the symbol IMC, and its ADSs and warrants are listed on NASDAQ under IMRN and IMRNW.

antibody engineeringclinical developmentmanufacturing process development

Compiled from public sources

Related capabilities

Other processes offered by the shops that list development and commercialisation of polyclonal antibodies.

Browse all capabilities